NSTC First Friday Seminar Series: Pfenex Inc.’s Evolution from a Platform Technology to a Product Development Company
Friday, October 4 2013
12:30 pm – 2:00 pm
Location: McLane Law Firm, 300 TradeCenter, 7th Floor, Woburn, MA
This NSTC First Friday Bioscience Series seminar will provide an overview of Pfenex’s evolution from a platform protein expression technology company to a product development company spurring value growth through a diversity of commercial approaches. Patrick Lucy, Vice President of Business Development and Marketing at Pfenex, will discuss how multiple funding sources, resource allocation, and differentiation enabled this transformation.
Patrick Lucy, Vice President of Business Development and Marketing, Pfenex Inc.
Mr. Lucy played a leadership role on the original team that developed Pfēnex Expression Technology™ and subsequently led the successful commercial launch of the platform in 2004. He has led the negotiation and completion of numerous technology partnering, licensing, manufacturing and collaboration agreements with the federal government and pharmaceutical companies worldwide. Mr. Lucy is experienced in the areas of alliance management, licensing, intellectual property, biopharmaceutical operations, and biopharmaceutical facility design, construction and validation. Prior to his role in Pfenex Inc., Mr. Lucy was employed by The Dow Chemical Company for nine years in business development roles for the Dowpharma business unit. Mr. Lucy has been in the biotechnology industry for over eighteen years and was previously employed by Collaborative BioAlliance, Inc., Lonza Biologics, Celltech Biologics and Repligen Corporation. Mr. Lucy holds a B.S. in Biology from Villanova University.
Refreshments Served: Pizza, salads, and soft drinks
Cost for Members and Non-members,
- Thanks to our host there is no charge for NSTC Members and Affiliates
- $10.00 for Non-Members
- Pre-register at http://www.nstc.org
- For more information, email FirstFridayBiosci@nstc.org
United States Biological (USB) is a primary brand for the Life Science Industry and supplies 350,000+ antibodies, biochemicals, research kits and cell culture media. UBS sells a full menu of products including Agar, Agarose, Amino Acids, Antibiotics, Antibodies, Biochemicals, Carbohydrates, Cell Culture, Bacterial and Yeast Media, Enzymes, Peptides, Human & Animal Sera, Molecular Biology Reagents, Purification and Separation Media, Assay Kits, Magnetic Kits, Metabolite Screen Kits and ELISA Kits. USB also provides custom services: Antibody Production and Conjugation, Protein and Enzyme Manufacturing, Peptide Synthesis, Mimetic Metabolite Screening and Production. USB has one primary goal and that is “Reducing the cost of research!” through competitive pricing and product selection.